Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05191017
Title Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nuvation Bio Inc.

prostate cancer


Enzalutamide + NUV-422

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.